Targeting autophagy as a potential therapeutic approach for melanoma therapy

Seminars in Cancer Biology

Volumn 23, Issue 5, 2013, Pages 352-360

  Liu, He ^a   He, Zhaoyue ^a   Simon, Hans Uwe ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Autophagy; Chemotherapy; Hypoxia; Immunotherapy; Melanoma

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 3 METHYLADENINE; AMINOLEVULINIC ACID; ANTINEOPLASTIC AGENT; AUTOPHAGY PROTEIN 5; B RAF KINASE; BAFILOMYCIN A1; BECLIN 1; CHLOROQUINE; CYCLOHEXIMIDE; DOXORUBICIN; ESOMEPRAZOLE; GANODERIC ACID DEXTROMETHORPHAN; GUANINE QUADRUPLEX; HYPOXIA INDUCIBLE FACTOR; JG 0314; LECTIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MERCAPTAMINE; METFORMIN; MICROTUBULE ASSOCIATED PROTEIN 1; MICROTUBULE ASSOCIATED PROTEIN 1 LIGHT CHAIN 3; POLYGONATUM CYRTONEMA LECTIN; POLYINOSINIC POLYCYTIDYLIC ACID; SANGUILUTINE; SORAFENIB; TEMOZOLOMIDE; TERFENADINE; TRITERPENOID; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; AUTOPHAGOSOME; AUTOPHAGY; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER THERAPY; HUMAN; HYPOXIA; MELANOMA; MELANOMA CELL; METABOLISM; MOLECULARLY TARGETED THERAPY; NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); PROTEIN EXPRESSION; REVIEW;

3-MA; 3-METHYLADENINE; 5-ALA; 5-AMINOLEVULINIC ACID; AMBRA1; ANTIGEN-PRESENTING CELL; APC; ARGININOSUCCINATE SYNTHETASE; ASS; ATAXIA TELANGIECTASIA MUTATED; ATG; ATM; AUTOPHAGY; AUTOPHAGY-RELATED; AUTOPHAGY/BECLIN 1 REGULATOR 1; BAFA1; BAFILOMYCIN A1; BENIGN NEVI; BIF-1; BN; CAV-1; CAVEOLIN-1; CHEMOTHERAPY; CHLOROQUINE; CQ; CTL; CTLA-4; CYTOLYTIC T LYMPHOCYTE; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; DDR; DEFECTIVE RIBOSOMAL PRODUCTS; DN; DNA DAMAGE RESPONSE; DRIPS; DYSPLASTIC NEVI; ELECTRON MICROSCOPY; EM; ENDOPHILIN B1; ENDOPLASMIC RETICULUM; ER; GA-DM; GANODERIC ACID-DEXTROMETHORPHAN; HIF; HLA; HUMAN LEUKOCYTE ANTIGEN; HYPOXIA; HYPOXIA-INDUCIBLE FACTOR; IFN; IMMUNOTHERAPY; INTERFERON; LAMP2; LC3; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 2; MAJOR HISTOCOMPATIBILITY COMPLEX; MAMMALIAN TARGET OF RAPAMYCIN; MELANOMA; MHC; MICROTUBULE-ASSOCIATED PROTEIN 1 LIGHT CHAIN 3; MTOR; PCL; PE; PEDF; PEI; PFS; PHOPHATIDYLINOSITOL-3-PHOSPHATE; PHOSPHATIDYLETHANOLAMINE; PHOSPHOINOSITIDE 3-KINASE; PI3K; PI3P; PIGMENT EPITHELIUM-DERIVED FACTOR RECEPTOR; POLYETHYLENE IMINE; POLYGONATUM CYRTONEMA LECTIN; PROGRESSION FREE SURVIVAL; RADIAL GROWTH PHASE; REACTIVE OXYGEN SPECIES; RGP; ROS; SKIN-DERIVED PRECURSOR; SKP; TISSUE MICROARRAY; TMA; TRAIL; TUMOR NECROSIS FACTOR-RELATED APOPTOSIS-INDUCING LIGAND; ULK1; UNC-51-LIKE KINASE 1; UV RADIATION RESISTANCE ASSOCIATED GENE; UVRAG; VERTICAL GROWTH PHASE; VGP;

ANIMALS; AUTOPHAGY; HUMANS; MELANOMA; SIGNAL TRANSDUCTION;

EID: 84884812963     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2013.06.008     Document Type: Review

References (88)

1. Reggiori F., Shintani T., Nair U., Klionsky D.J. Atg9 cycles between mitochondria and the pre-autophagosomal structure in yeasts. Autophagy 2005, 1(2):101-109.
2. Hayashi-Nishino M., Fujita N., Noda T., Yamaguchi A., Yoshimori T., Yamamoto A. A subdomain of the endoplasmic reticulum forms a cradle for autophagosome formation. Nat Cell Biol 2009, 11(12):1433-1437.
3. Hayashi-Nishino M., Fujita N., Noda T., Yamaguchi A., Yoshimori T., Yamamoto A. Electron tomography reveals the endoplasmic reticulum as a membrane source for autophagosome formation. Autophagy 2010, 6(2):301-303.
4. Cuervo A.M. Autophagy in sickness and in health. Trends Cell Biol 2004, 14(2):70-77.
5. Mizushima N., Levine B., Cuervo A.M., Klionsky D.J. Autophagy fights disease through cellular self-digestion. Nature 2008, 451(7182):1069-1075.
6. Shintani T., Klionsky D.J. Autophagy in health and disease: a double-edged sword. Science 2004, 306(5698):990-995.
7. Levine B., Klionsky D.J. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell 2004, 6(4):463-477.
8. Levine B., Yuan J. Autophagy in cell death: an innocent convict?. J Clin Invest 2005, 115(10):2679-2688.
9. Yousefi S., Simon H.U. Apoptosis regulation by autophagy gene 5. Crit Rev Oncol Hematol 2007, 63(3):241-244.
10. Wu Y.T., Tan H.L., Shui G., Bauvy C., Huang Q., Wenk M.R., et al. Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase. J Biol Chem 2010, 285(14):10850-10861.
11. Levine B., Mizushima N., Virgin H.W. Autophagy in immunity and inflammation. Nature 2011, 469(7330):323-335.
12. Wirawan E., Vanden Berghe T., Lippens S., Agostinis P., Vandenabeele P. Autophagy: for better or for worse. Cell Res 2012, 22(1):43-61.
13. Yousefi S., Perozzo R., Schmid I., Ziemiecki A., Schaffner T., Scapozza L., et al. Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nat Cell Biol 2006, 8(10):1124-1132.
14. Pattingre S., Tassa A., Qu X., Garuti R., Liang X.H., Mizushima N., et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005, 122(6):927-939.
15. Chen Z.H., Lam H.C., Jin Y., Kim H.P., Cao J., Lee S.J., et al. Autophagy protein microtubule-associated protein 1 light chain-3B (LC3B) activates extrinsic apoptosis during cigarette smoke-induced emphysema. Proc Natl Acad Sci USA 2010, 107(44):18880-18885.
16. Kroemer G., Mariño G., Levine B. Autophagy and the integrated stress response. Mol Cell 2010, 40(2):280-293.
17. Mizushima N., Levine B. Autophagy in mammalian development and differentiation. Nat Cell Biol 2010, 12(9):823-830.
18. Rubinsztein D.C., Mariño G., Kroemer G. Autophagy and aging. Cell 2011, 146(5):682-695.
19. Rubinsztein D.C., Codogno P., Levine B. Autophagy modulation as a potential therapeutic target for diverse diseases. Nat Rev Drug Discov 2012, 11(9):709-730.
20. Rubinsztein D.C. The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 2006, 443(7113):780-786.
21. Martinez-Vicente M., Cuervo A.M. Autophagy and neurodegeneration: when the cleaning crew goes on strike. Lancet Neurol 2007, 6(4):352-361.
22. Tannous P., Zhu H., Johnstone J.L., Shelton J.M., Rajasekaran N.S., Benjamin I.J., et al. Autophagy is an adaptive response in desmin-related cardiomyopathy. Proc Natl Acad Sci USA 2008, 105(28):9745-9750.
23. Kirshenbaum L.A. Regulation of autophagy in the heart in health and disease. J Cardiovasc Pharmacol 2012, 60(2):109.
24. He C., Bassik M.C., Moresi V., Sun K., Wei Y., Zou Z., et al. Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis. Nature 2012, 481(7382):511-515.
25. Yang L., Li P., Fu S., Calay E.S., Hotamisligil G.S. Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab 2010, 11(6):467-478.
26. Singh R., Xiang Y., Wang Y., Baikati K., Cuervo A.M., Luu Y.K., et al. Autophagy regulates adipose mass and differentiation in mice. J Clin Invest 2009, 119(11):3329-3339.
27. Chen Z.H., Kim H.P., Sciurba F.C., Lee S.J., Feghali-Bostwick C., Stolz D.B., et al. Egr-1 regulates autophagy in cigarette smoke-induced chronic obstructive pulmonary disease. PLoS ONE 2008, 3(10):e3316.
28. Luciani A., Villella V.R., Esposito S., Brunetti-Pierri N., Medina D., Settembre C., et al. Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition. Nat Cell Biol 2010, 12(9):863-875.
29. Patel A.S., Lin L., Geyer A., Haspel J.A., An C.H., Cao J., et al. Autophagy in idiopathic pulmonary fibrosis. PLoS ONE 2012, 7(7):e41394.
30. Yousefi S., Simon H.U. Autophagy in cancer and chemotherapy. Results Probl Cell Differ 2009, 49:183-190.
31. White E. Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer 2012, 12(6):401-410.
32. Choi A.M., Ryter S.W., Levine B. Autophagy in human health and disease. N Engl J Med 2013, 368(7):651-662.
33. Gozuacik D., Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene 2004, 23(16):2891-2906.
34. Tschan M.P., Simon H.U. The role of autophagy in anticancer therapy: promises and uncertainties. J Intern Med 2010, 268(5):410-418.
35. Young A.R., Narita M., Ferreira M., Kirschner K., Sadaie M., Darot J.F., et al. Autophagy mediates the mitotic senescence transition. Genes Dev 2009, 23(7):798-803.
36. Liang X.H., Jackson S., Seaman M., Brown K., Kempkes B., Hibshoosh H., et al. Induction of autophagy and inhibition of tumorigenesis by Beclin1. Nature 1999, 420(6762):672-676.
37. Saito H., Inazawa J., Saito S., Kasumi F., Koi S., Sagae S., et al. Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors. Cancer Res 1993, 53(14):3382-3385.
38. Gao X., Zacharek A., Salkowski A., Grignon D.J., Sakr W., Porter A.T., et al. Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer. Cancer Res 1995, 55(5):1002-1005.
39. Liang C., Feng P., Ku B., Dotan I., Canaani D., Oh B.H., et al. Autophagic and tumor suppressor activity of a novel Beclin1-binding protein UVRAG. Nat Cell Biol 2006, 8(7):688-699.
40. Takahashi Y., Coppola D., Matsushita N., Cualing H.D., Sun M., Sato Y., et al. Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis. Nat Cell Biol 2007, 9(10):1142-1151.
41. Takamura A., Komatsu M., Hara T., Sakamoto A., Kishi C., Waguri S., et al. Autophagy-deficient mice develop multiple liver tumors. Genes Dev 2011, 25(8):795-800.
42. Guertin D.A., Sabatini D.M. Defining the role of mTOR in cancer. Cancer Cell 2007, 12(1):9-22.
43. Díaz-Troya S., Pérez-Pérez M.E., Florencio F.J., Crespo J.L. The role of TOR in autophagy regulation from yeast to plants and mammals. Autophagy 2008, 4(7):851-865.
44. Klionsky D.J., Abdalla F.C., Abeliovich H., Abraham R.T., Acevedo-Arozena A., Adeli K., et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012, 8(4):445-544.
45. Lazova R., Klump V., Pawelek J. Autophagy in cutaneous malignant melanoma. J Cutan Pathol 2010, 37(2):256-268.
46. Miracco C., Cevenini G., Franchi A., Luzi P., Cosci E., Mourmouras V., et al. Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions. Hum Pathol 2010, 41(4):503-512.
47. Hara Y., Nakamura M. Overexpression of autophagy-related beclin-1 in advanced malignant melanoma and its low expression in melanoma-in-situ. Eur J Dermatol 2012, 22(1):128-129.
48. Sivridis E., Koukourakis M.I., Mendrinos S.E., Karpouzis A., Fiska A., Kouskoukis C., et al. Beclin-1 and LC3A expression in cutaneous malignant melanomas: a biphasic survival pattern for beclin-1. Melanoma Res 2011, 21(3):188-195.
49. Ma X.H., Piao S., Wang D., McAfee Q.W., Nathanson K.L., Lum J.J., et al. Measurements of tumor cell autophagy predict invasiveness, resistance to chemotherapy, and survival in melanoma. Clin Cancer Res 2011, 17(10):3478-3489.
50. Marino M.L., Fais S., Djavaheri-Mergny M., Villa A., Meschini S., Lozupone F., et al. Proton pump inhibition induces autophagy as a survival mechanism following oxidative stress in human melanoma cells. Cell Death Dis 2010, 1:e87.
51. Hammerová J., Uldrijan S., Táborská E., Vaculová A.H., Slaninová I. Necroptosis modulated by autophagy is a predominant form of melanoma cell death induced by sanguilutine. Biol Chem 2012, 393(7):647-658.
52. Düchler M. G-quadruplexes: targets and tools in anticancer drug design. J Durg Target 2012, 20(5):389-400.
53. Orlotti N.I., Cimino-Reale G., Borghini E., Pennati M., Sissi C., Perrone F., et al. Autophagy acts as a safeguard mechanism against G-quadruplex ligand-mediated DNA damage. Autophagy 2012, 8(8):1185-1196.
54. Marino M.L., Pellegrini P., Di Lernia G., Djavaheri-Mergny M., Brnjic S., Zhang X., et al. Autophagy is a protective mechanism for human melanoma cells under acidic stress. J Biol Chem 2012, 287(36):30664-30676.
55. Dominy J.E., Simmons C.R., Hirschberger L.L., Hwang J., Coloso R.M., Stipanuk M.H. Discovery and characterization of a second mammalian thiol dioxygenase, cysteamine dioxygenase. J Biol Chem 2007, 282(35):25189-25198.
56. Wan X.M., Zheng F., Zhang L., Miao Y.Y., Man N., Wen L.P. Autophagy-mediated chemosensitization by cysteamine in cancer cells. Int J Cancer 2011, 129(5):1087-1095.
57. Bailey C.J., Turner R.C. Metformin. N Engl J Med 1996, 334(9):574-579.
58. Tomic T., Botton T., Cerezo M., Robert G., Luciano F., Puissant A., et al. Metformin inhibits melanoma development through autophagy and apoptosis mechanisms. Cell Death Dis 2011, 2:e199.
59. Nicolau-Galmés F., Asumendi A., Alonso-Tejerina E., Pérez-Yarza G., Jangi S.M., Gardeazabal J., et al. Terfenadine induces apoptosis and autophagy in melanoma cells through ROS-dependent and -independent mechanisms. Apoptosis 2011, 16(12):1253-1267.
60. Liu B., Cheng Y., Zhang B., Bian H.J., Bao J.K. Polygonatum cyrtonema lectin induces apoptosis and autophagy in human melanoma A375 cells through a mitochondria-mediated ROS-p38-p53 pathway. Cancer Lett 2009, 275(1):54-60.
61. Biggers J.W., Nguyen T., Di X., Gupton J.T., Henderson S.C., Emery S.M., et al. Autophagy, cell death and sustained senescence arrest in B16/F10 melanoma cells and HCT-116 colon carcinoma cells in response to the novel microtubule poison, JG-03-14. Cancer Chemother Pharmacol 2013, 71(2):441-455.
62. Lakhter A.J., Sahu R.P., Sun Y., Kaufmann W.K., Androphy E.J., Travers J.B., et al. Chloroquine promotes apoptosis in melanoma cells by inhibiting BH3 domain mediated PUMA degradation. J Invest Dermatol 2013, 10.1038/jid.2013.56.
63. Sparsa A., Bellaton S., Naves T., Jauberteau M.O., Bonnetblanc J.M., Sol V., et al. Photodynamic treatment induces cell death by apoptosis or autophagy depending on the melanin content in two B16 melanoma cell lines. Oncol Rep 2013, 29(3):1196-1200.
64. Flaherty K.T., Infante J.R., Daud A., Gonzalez R., Kefford R.F., Sosman J., et al. Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations. N Engl J Med 2012, 367(18):1694-1703.
65. Sosman J.A., Kim K.B., Schuchter L., Gonzalez R., Pavlick A.C., Weber J.S., et al. Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib. N Engl J Med 2012, 366(8):707-714.
66. Cheong H., Lindsten T., Thompson C.B. Autophagy and ammonia. Autophagy 2012, 8(1):122-123.
67. Sheen J.H., Zoncu R., Kim D., Sabatini D.M. Defective regulation of autophagy upon leucine deprivation reveals a targetable liability of human melanoma cells in vitro and in vivo. Cancer Cell 2011, 19(5):613-628.
68. You M., Savaraj N., Kuo M.T., Wangpaichitr M., Varona-Santos J., Wu C., et al. TRAIL induces autophagic protein cleavage through caspase activation in melanoma cell lines under arginine deprivation. Mol Cell Biochem 2013, 374(1/2):181-190.
69. Harhaji-Trajkovic L., Arsikin K., Kravic-Stevovic T., Petricevic S., Tovilovic G., Pantovic A., et al. Chloroquine-mediated lysosomal dysfunction enhances the anticancer effect of nutrient deprivation. Pharm Res 2012, 29(8):2249-2263.
70. Kennedy B.K., Steffen K.K., Kaeberlein M. Ruminations on dietary restriction and aging. Cell Mol Life Sci 2007, 64(11):1323-1328.
71. Omodei D., Fontana L. Calorie restriction and prevention of age-associated chronic disease. FEBS Lett 2011, 585(11):1537-1542.
72. 2. Biochem Pharmacol 2013, 85(8):1153-1161.
73. Giatromanolaki A., Koukourakis M.I., Koutsopoulos A.V., Harris A.L., Gatter K., Sivridis E. Autophagy and hypoxia in colonic adenomas related to aggressive features. Colorectal Dis 2013, 15(5):e223-e230.
74. Lee S.J., Kim H.P., Jin Y., Choi A.M., Ryter S.W. Beclin 1 deficiency is associated with increased hypoxia-induced angiogenesis. Autophagy 2011, 7(8):829-839.
75. Noman M.Z., Janji B., Kaminska B., Van Moer K., Pierson S., Przanowski P., et al. Blocking hypoxia-induced autophagy in tumors restores cytotoxic T-cell activity and promotes regression. Cancer Res 2011, 71(18):5976-5986.
76. Fernández-Barral A., Orgaz J.L., Gomez V., del Peso L., Calzada M.J., Jiménez B. Hypoxia negatively regulates antimetastatic PEDF in melanoma cells by a hypoxia inducible factor-independent, autophagy dependent mechanism. PLoS ONE 2012, 7(3):e32989.
77. Boasberg P., Hamid O., O'Day S., Ipilimumab: unleashing the power of the immune system through CTLA-4 blockade. Semin Oncol 2010, 37(5):440-449.
78. Levine B., Deretic V. Unveiling the roles of autophagy in innate and adaptive immunity. Nat Rev Immunol 2007, 7(10):767-777.
79. Tormo D., Checińska A., Alonso-Curbelo D., Pérez-Guijarro E., Cañón E., Riveiro-Falkenbach E., et al. Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cells. Cancer Cell 2009, 16(2):103-114.
80. Boh B., Berovic M., Zhang J., Zhi-Bin L. Ganoderma lucidum and its pharmaceutically active compounds. Biotechnol Annu Rev 2007, 13:265-301.
81. Hossain A., Radwan F.F., Doonan B.P., God J.M., Zhang L., Bell P.D., et al. A possible cross-talk between autophagy and apoptosis in generating an immune response in melanoma. Apoptosis 2012, 17(10):1066-1078.
82. McDougall C.J., Ngoi S.S., Goldman I.S., Godwin T., Felix J., DeCosse J.J., et al. Reduced expression of HLA class I and II antigens in colon cancer. Cancer Res 1990, 50(24):8023-8027.
83. Hicklin D.J., Marincola F.M., Ferrone S. HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story. Mol Med Today 1999, 5(4):178-186.
84. Münz C. Antigen processing for MHC class II presentation via autophagy. Front Immunol 2012, 3:9.
85. Li B., Lei Z., Lichty B.D., Li D., Zhang G.M., Feng Z.H., et al. Autophagy facilitates major histocompatibility complex class I expression induced by IFN-γ in B16 melanoma cells. Cancer Immunol Immunother 2010, 59(2):313-321.
86. Li Y., Wang L.X., Yang G., Hao F., Urba W.J., Hu H.M. Efficient cross-presentation depends on autophagy in tumor cells. Cancer Res 2008, 68(17):6889-6895.
87. Li Y., Wang L.X., Pang P., Cui Z., Aung S., Haley D., et al. Tumor-derived autophagosome vaccine: mechanism of cross-presentation and therapeutic efficacy. Clin Cancer Res 2011, 17(22):7047-7057.
88. Salemi S., Yousefi S., Constantinescu M.A., Fey M.F., Simon H.U. Autophagy is required for self-renewal and differentiation of adult human stem cells. Cell Res 2012, 22(2):432-435.